Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Arlington, Va., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Experts from the American Institutes for Research (AIR) will present at several sessions during the Association for Public Policy Analysis and...
-
DENVER, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Axcient, a leader in business availability software for Managed Service Providers (MSPs), today announced key findings on how MSPs are consolidating their...
-
10. November 2022 07:00 ET | Quelle: Centre d’excellence sur la douleur chronique pour les vétérans canadiens
HAMILTON, Ontario, 10 nov. 2022 (GLOBE NEWSWIRE) -- Le Centre d’excellence sur la douleur chronique pour les vétérans canadiens (CESLDC) est heureux d’annoncer la nomination du lieutenant-général...
-
HAMILTON, Ontario, Nov. 10, 2022 (GLOBE NEWSWIRE) -- The Chronic Pain Centre of Excellence for Canadian Veterans (CPCoE) is excited to announce it has appointed Lieutenant-General (retired) J.O....
-
Salt Lake City, UT, Nov. 09, 2022 (GLOBE NEWSWIRE) -- A new study by researchers at Intermountain Healthcare in Salt Lake City finds that the most commonly prescribed class of anti-depressants does...
-
Abu Dhabi, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Insilico Medicine, a clinical stage artificial intelligence (AI)-driven drug discovery company, announced a multi-year, multi-target strategic research...
-
New York, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Insilico Medicine, a clinical stage artificial intelligence (AI)-driven drug discovery company, announced a multi-year, multi-target strategic research...
-
CAMBRIDGE, Mass., Nov. 07, 2022 (GLOBE NEWSWIRE) -- The Symposium on Electronic Crime Research (APWG eCrime) is now open for submissions to its General Sessions -- those papers, presentations and...
-
Dublin, Nov. 07, 2022 (GLOBE NEWSWIRE) -- The "Network Engineering Services Market by Service Type (Network Assessment, Network Design, Network Deployment), Transmission Mode (Wired, Wireless),...
-
– Data from multiple ongoing trials evaluating Vir’s two novel HBV therapies continue to demonstrate substantial reductions in hepatitis B surface antigen (HBsAg) with no new safety signals – –...